世界の人工関節感染症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Prosthetic Joint Infections Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4776 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、人工関節感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（フシジン酸、酢酸レファムリン、MTF-101、TNP-2092、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・人工関節感染症治療の市場動向 ・企業の競争状況、市場シェア ・人工関節感染症治療の種類別市場規模と予測2016-2027（フシジン酸、酢酸レファムリン、MTF-101、TNP-2092、その他） ・人工関節感染症治療の用途別市場規模と予測2016-2027（病院、クリニック、その他） ・人工関節感染症治療の北米市場規模2016-2027（アメリカ、カナダ） ・人工関節感染症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・人工関節感染症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・人工関節感染症治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・人工関節感染症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Cempra Inc、Motif Bio Plc、Nabriva Therapeutics AG、Telephus Medical LLC、TenNor Therapeutics Ltd） ・結論

Market Analysis and Insights: Global Prosthetic Joint Infections Treatment Market
The global Prosthetic Joint Infections Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Prosthetic Joint Infections Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Prosthetic Joint Infections Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Prosthetic Joint Infections Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Prosthetic Joint Infections Treatment market.

Global Prosthetic Joint Infections Treatment Scope and Market Size
Prosthetic Joint Infections Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Prosthetic Joint Infections Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Fusidic acid
Lefamulin Acetate
MTF-101
TNP-2092
Others

Segment by Application
Hospital
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Cempra Inc
Motif Bio Plc
Nabriva Therapeutics AG
Telephus Medical LLC
TenNor Therapeutics Ltd

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prosthetic Joint Infections Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Fusidic acid
1.2.3 Lefamulin Acetate
1.2.4 MTF-101
1.2.5 TNP-2092
1.2.6 Others
1.3 Market by Application
1.3.1 Global Prosthetic Joint Infections Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Prosthetic Joint Infections Treatment Market Perspective (2016-2027)
2.2 Prosthetic Joint Infections Treatment Growth Trends by Regions
2.2.1 Prosthetic Joint Infections Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Prosthetic Joint Infections Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Prosthetic Joint Infections Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Prosthetic Joint Infections Treatment Industry Dynamic
2.3.1 Prosthetic Joint Infections Treatment Market Trends
2.3.2 Prosthetic Joint Infections Treatment Market Drivers
2.3.3 Prosthetic Joint Infections Treatment Market Challenges
2.3.4 Prosthetic Joint Infections Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Prosthetic Joint Infections Treatment Players by Revenue
3.1.1 Global Top Prosthetic Joint Infections Treatment Players by Revenue (2016-2021)
3.1.2 Global Prosthetic Joint Infections Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Prosthetic Joint Infections Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Prosthetic Joint Infections Treatment Revenue
3.4 Global Prosthetic Joint Infections Treatment Market Concentration Ratio
3.4.1 Global Prosthetic Joint Infections Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prosthetic Joint Infections Treatment Revenue in 2020
3.5 Prosthetic Joint Infections Treatment Key Players Head office and Area Served
3.6 Key Players Prosthetic Joint Infections Treatment Product Solution and Service
3.7 Date of Enter into Prosthetic Joint Infections Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Prosthetic Joint Infections Treatment Breakdown Data by Type
4.1 Global Prosthetic Joint Infections Treatment Historic Market Size by Type (2016-2021)
4.2 Global Prosthetic Joint Infections Treatment Forecasted Market Size by Type (2022-2027)

5 Prosthetic Joint Infections Treatment Breakdown Data by Application
5.1 Global Prosthetic Joint Infections Treatment Historic Market Size by Application (2016-2021)
5.2 Global Prosthetic Joint Infections Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Prosthetic Joint Infections Treatment Market Size (2016-2027)
6.2 North America Prosthetic Joint Infections Treatment Market Size by Type
6.2.1 North America Prosthetic Joint Infections Treatment Market Size by Type (2016-2021)
6.2.2 North America Prosthetic Joint Infections Treatment Market Size by Type (2022-2027)
6.2.3 North America Prosthetic Joint Infections Treatment Market Size by Type (2016-2027)
6.3 North America Prosthetic Joint Infections Treatment Market Size by Application
6.3.1 North America Prosthetic Joint Infections Treatment Market Size by Application (2016-2021)
6.3.2 North America Prosthetic Joint Infections Treatment Market Size by Application (2022-2027)
6.3.3 North America Prosthetic Joint Infections Treatment Market Size by Application (2016-2027)
6.4 North America Prosthetic Joint Infections Treatment Market Size by Country
6.4.1 North America Prosthetic Joint Infections Treatment Market Size by Country (2016-2021)
6.4.2 North America Prosthetic Joint Infections Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Prosthetic Joint Infections Treatment Market Size (2016-2027)
7.2 Europe Prosthetic Joint Infections Treatment Market Size by Type
7.2.1 Europe Prosthetic Joint Infections Treatment Market Size by Type (2016-2021)
7.2.2 Europe Prosthetic Joint Infections Treatment Market Size by Type (2022-2027)
7.2.3 Europe Prosthetic Joint Infections Treatment Market Size by Type (2016-2027)
7.3 Europe Prosthetic Joint Infections Treatment Market Size by Application
7.3.1 Europe Prosthetic Joint Infections Treatment Market Size by Application (2016-2021)
7.3.2 Europe Prosthetic Joint Infections Treatment Market Size by Application (2022-2027)
7.3.3 Europe Prosthetic Joint Infections Treatment Market Size by Application (2016-2027)
7.4 Europe Prosthetic Joint Infections Treatment Market Size by Country
7.4.1 Europe Prosthetic Joint Infections Treatment Market Size by Country (2016-2021)
7.4.2 Europe Prosthetic Joint Infections Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Prosthetic Joint Infections Treatment Market Size (2016-2027)
8.2 Asia-Pacific Prosthetic Joint Infections Treatment Market Size by Type
8.2.1 Asia-Pacific Prosthetic Joint Infections Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Prosthetic Joint Infections Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Prosthetic Joint Infections Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Prosthetic Joint Infections Treatment Market Size by Application
8.3.1 Asia-Pacific Prosthetic Joint Infections Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Prosthetic Joint Infections Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Prosthetic Joint Infections Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Prosthetic Joint Infections Treatment Market Size by Region
8.4.1 Asia-Pacific Prosthetic Joint Infections Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Prosthetic Joint Infections Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Prosthetic Joint Infections Treatment Market Size (2016-2027)
9.2 Latin America Prosthetic Joint Infections Treatment Market Size by Type
9.2.1 Latin America Prosthetic Joint Infections Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Prosthetic Joint Infections Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Prosthetic Joint Infections Treatment Market Size by Type (2016-2027)
9.3 Latin America Prosthetic Joint Infections Treatment Market Size by Application
9.3.1 Latin America Prosthetic Joint Infections Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Prosthetic Joint Infections Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Prosthetic Joint Infections Treatment Market Size by Application (2016-2027)
9.4 Latin America Prosthetic Joint Infections Treatment Market Size by Country
9.4.1 Latin America Prosthetic Joint Infections Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Prosthetic Joint Infections Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Prosthetic Joint Infections Treatment Market Size (2016-2027)
10.2 Middle East & Africa Prosthetic Joint Infections Treatment Market Size by Type
10.2.1 Middle East & Africa Prosthetic Joint Infections Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Prosthetic Joint Infections Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Prosthetic Joint Infections Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Prosthetic Joint Infections Treatment Market Size by Application
10.3.1 Middle East & Africa Prosthetic Joint Infections Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Prosthetic Joint Infections Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Prosthetic Joint Infections Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Prosthetic Joint Infections Treatment Market Size by Country
10.4.1 Middle East & Africa Prosthetic Joint Infections Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Prosthetic Joint Infections Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Cempra Inc
11.1.1 Cempra Inc Company Details
11.1.2 Cempra Inc Business Overview
11.1.3 Cempra Inc Prosthetic Joint Infections Treatment Introduction
11.1.4 Cempra Inc Revenue in Prosthetic Joint Infections Treatment Business (2016-2021)
11.1.5 Cempra Inc Recent Development
11.2 Motif Bio Plc
11.2.1 Motif Bio Plc Company Details
11.2.2 Motif Bio Plc Business Overview
11.2.3 Motif Bio Plc Prosthetic Joint Infections Treatment Introduction
11.2.4 Motif Bio Plc Revenue in Prosthetic Joint Infections Treatment Business (2016-2021)
11.2.5 Motif Bio Plc Recent Development
11.3 Nabriva Therapeutics AG
11.3.1 Nabriva Therapeutics AG Company Details
11.3.2 Nabriva Therapeutics AG Business Overview
11.3.3 Nabriva Therapeutics AG Prosthetic Joint Infections Treatment Introduction
11.3.4 Nabriva Therapeutics AG Revenue in Prosthetic Joint Infections Treatment Business (2016-2021)
11.3.5 Nabriva Therapeutics AG Recent Development
11.4 Telephus Medical LLC
11.4.1 Telephus Medical LLC Company Details
11.4.2 Telephus Medical LLC Business Overview
11.4.3 Telephus Medical LLC Prosthetic Joint Infections Treatment Introduction
11.4.4 Telephus Medical LLC Revenue in Prosthetic Joint Infections Treatment Business (2016-2021)
11.4.5 Telephus Medical LLC Recent Development
11.5 TenNor Therapeutics Ltd
11.5.1 TenNor Therapeutics Ltd Company Details
11.5.2 TenNor Therapeutics Ltd Business Overview
11.5.3 TenNor Therapeutics Ltd Prosthetic Joint Infections Treatment Introduction
11.5.4 TenNor Therapeutics Ltd Revenue in Prosthetic Joint Infections Treatment Business (2016-2021)
11.5.5 TenNor Therapeutics Ltd Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Prosthetic Joint Infections Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Fusidic acid
Table 3. Key Players of Lefamulin Acetate
Table 4. Key Players of MTF-101
Table 5. Key Players of TNP-2092
Table 6. Key Players of Others
Table 7. Global Prosthetic Joint Infections Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Prosthetic Joint Infections Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Prosthetic Joint Infections Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Prosthetic Joint Infections Treatment Market Share by Regions (2016-2021)
Table 11. Global Prosthetic Joint Infections Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Prosthetic Joint Infections Treatment Market Share by Regions (2022-2027)
Table 13. Prosthetic Joint Infections Treatment Market Trends
Table 14. Prosthetic Joint Infections Treatment Market Drivers
Table 15. Prosthetic Joint Infections Treatment Market Challenges
Table 16. Prosthetic Joint Infections Treatment Market Restraints
Table 17. Global Prosthetic Joint Infections Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Prosthetic Joint Infections Treatment Market Share by Players (2016-2021)
Table 19. Global Top Prosthetic Joint Infections Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prosthetic Joint Infections Treatment as of 2020)
Table 20. Ranking of Global Top Prosthetic Joint Infections Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Prosthetic Joint Infections Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Prosthetic Joint Infections Treatment Product Solution and Service
Table 24. Date of Enter into Prosthetic Joint Infections Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Prosthetic Joint Infections Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Prosthetic Joint Infections Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Prosthetic Joint Infections Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Prosthetic Joint Infections Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Prosthetic Joint Infections Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Prosthetic Joint Infections Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Prosthetic Joint Infections Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Prosthetic Joint Infections Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Prosthetic Joint Infections Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Prosthetic Joint Infections Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Prosthetic Joint Infections Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Prosthetic Joint Infections Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Prosthetic Joint Infections Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Prosthetic Joint Infections Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Prosthetic Joint Infections Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Prosthetic Joint Infections Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Prosthetic Joint Infections Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Prosthetic Joint Infections Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Prosthetic Joint Infections Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Prosthetic Joint Infections Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Prosthetic Joint Infections Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Prosthetic Joint Infections Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Prosthetic Joint Infections Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Prosthetic Joint Infections Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Prosthetic Joint Infections Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Prosthetic Joint Infections Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Prosthetic Joint Infections Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Prosthetic Joint Infections Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Prosthetic Joint Infections Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Prosthetic Joint Infections Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Prosthetic Joint Infections Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Prosthetic Joint Infections Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Prosthetic Joint Infections Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Prosthetic Joint Infections Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Prosthetic Joint Infections Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Prosthetic Joint Infections Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Prosthetic Joint Infections Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Prosthetic Joint Infections Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. Cempra Inc Company Details
Table 65. Cempra Inc Business Overview
Table 66. Cempra Inc Prosthetic Joint Infections Treatment Product
Table 67. Cempra Inc Revenue in Prosthetic Joint Infections Treatment Business (2016-2021) & (US$ Million)
Table 68. Cempra Inc Recent Development
Table 69. Motif Bio Plc Company Details
Table 70. Motif Bio Plc Business Overview
Table 71. Motif Bio Plc Prosthetic Joint Infections Treatment Product
Table 72. Motif Bio Plc Revenue in Prosthetic Joint Infections Treatment Business (2016-2021) & (US$ Million)
Table 73. Motif Bio Plc Recent Development
Table 74. Nabriva Therapeutics AG Company Details
Table 75. Nabriva Therapeutics AG Business Overview
Table 76. Nabriva Therapeutics AG Prosthetic Joint Infections Treatment Product
Table 77. Nabriva Therapeutics AG Revenue in Prosthetic Joint Infections Treatment Business (2016-2021) & (US$ Million)
Table 78. Nabriva Therapeutics AG Recent Development
Table 79. Telephus Medical LLC Company Details
Table 80. Telephus Medical LLC Business Overview
Table 81. Telephus Medical LLC Prosthetic Joint Infections Treatment Product
Table 82. Telephus Medical LLC Revenue in Prosthetic Joint Infections Treatment Business (2016-2021) & (US$ Million)
Table 83. Telephus Medical LLC Recent Development
Table 84. TenNor Therapeutics Ltd Company Details
Table 85. TenNor Therapeutics Ltd Business Overview
Table 86. TenNor Therapeutics Ltd Prosthetic Joint Infections Treatment Product
Table 87. TenNor Therapeutics Ltd Revenue in Prosthetic Joint Infections Treatment Business (2016-2021) & (US$ Million)
Table 88. TenNor Therapeutics Ltd Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prosthetic Joint Infections Treatment Market Share by Type: 2020 VS 2027
Figure 2. Fusidic acid Features
Figure 3. Lefamulin Acetate Features
Figure 4. MTF-101 Features
Figure 5. TNP-2092 Features
Figure 6. Others Features
Figure 7. Global Prosthetic Joint Infections Treatment Market Share by Application: 2020 VS 2027
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Prosthetic Joint Infections Treatment Report Years Considered
Figure 12. Global Prosthetic Joint Infections Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Prosthetic Joint Infections Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Prosthetic Joint Infections Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Prosthetic Joint Infections Treatment Market Share by Regions (2022-2027)
Figure 16. Global Prosthetic Joint Infections Treatment Market Share by Players in 2020
Figure 17. Global Top Prosthetic Joint Infections Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prosthetic Joint Infections Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Prosthetic Joint Infections Treatment Revenue in 2020
Figure 19. Global Prosthetic Joint Infections Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Prosthetic Joint Infections Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Prosthetic Joint Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Prosthetic Joint Infections Treatment Market Share by Type (2016-2027)
Figure 23. North America Prosthetic Joint Infections Treatment Market Share by Application (2016-2027)
Figure 24. North America Prosthetic Joint Infections Treatment Market Share by Country (2016-2027)
Figure 25. United States Prosthetic Joint Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Prosthetic Joint Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Prosthetic Joint Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Prosthetic Joint Infections Treatment Market Share by Type (2016-2027)
Figure 29. Europe Prosthetic Joint Infections Treatment Market Share by Application (2016-2027)
Figure 30. Europe Prosthetic Joint Infections Treatment Market Share by Country (2016-2027)
Figure 31. Germany Prosthetic Joint Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Prosthetic Joint Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Prosthetic Joint Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Prosthetic Joint Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Prosthetic Joint Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Prosthetic Joint Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Prosthetic Joint Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Prosthetic Joint Infections Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Prosthetic Joint Infections Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Prosthetic Joint Infections Treatment Market Share by Region (2016-2027)
Figure 41. China Prosthetic Joint Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Prosthetic Joint Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Prosthetic Joint Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Prosthetic Joint Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Prosthetic Joint Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Prosthetic Joint Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Prosthetic Joint Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Prosthetic Joint Infections Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Prosthetic Joint Infections Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Prosthetic Joint Infections Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Prosthetic Joint Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Prosthetic Joint Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Prosthetic Joint Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Prosthetic Joint Infections Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Prosthetic Joint Infections Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Prosthetic Joint Infections Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Prosthetic Joint Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Prosthetic Joint Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Prosthetic Joint Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Cempra Inc Revenue Growth Rate in Prosthetic Joint Infections Treatment Business (2016-2021)
Figure 61. Motif Bio Plc Revenue Growth Rate in Prosthetic Joint Infections Treatment Business (2016-2021)
Figure 62. Nabriva Therapeutics AG Revenue Growth Rate in Prosthetic Joint Infections Treatment Business (2016-2021)
Figure 63. Telephus Medical LLC Revenue Growth Rate in Prosthetic Joint Infections Treatment Business (2016-2021)
Figure 64. TenNor Therapeutics Ltd Revenue Growth Rate in Prosthetic Joint Infections Treatment Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

---